跳至主要内容
临床试验/ACTRN12623000893606
ACTRN12623000893606尚未招募Unknown

Effect of a Toothpaste containing Casein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACP) and Stannous Fluoride on Supragingival Plaque Composition and Gingivitis in Healthy Adults

The University of Melbourne0 个研究点目标入组 40 人开始时间: 2023年8月21日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • Inclusion Criteria:
  • To be eligible to participate in this study, an individual must meet all of the following criteria:
  • 1.Ability to understand, and willingness and ability to read and sign, the informed consent form.
  • 2.Age range: 18 to 75 years old.
  • 3.Good general health.
  • 4.Minimum of 20 natural teeth.
  • 5.A gum-stimulated whole salivary flow rate greater than or equal to 1.0 ml/minute and unstimulated whole salivary flow rate greater than or equal to 0.2 ml/minute.
  • 6.A baseline mean whole-mouth modified gingival index greater than or equal to 1.5.
  • 7.A baseline mean whole-mouth plaque index greater than or equal to 1.5.
  • 8.A baseline mean whole-mouth sulcus bleeding index greater than or equal to 1.0.
  • 9.Willingness to comply with all study procedures and be available for the duration of the study.

排除标准

  • Exclusion Criteria:
  • Individuals who manifest ANY of the following exclusion criteria at the time of randomization will NOT be eligible for the study:
  • 1.Allergy to milk protein, tin or other ingredients in toothpaste products.
  • 2.Orthodontic appliances or removable prostheses.
  • 3.Veneers, or more than one incisor with a prosthetic crown.
  • 4.Gross oral pathology (including periodontal disease {Community Periodontal Index of Treatment Needs [CPITN] greater than or equal to 3} and tumours of the soft or hard oral tissues).
  • 5.Chronic disease with concomitant oral manifestations (e.g., diabetes [irrespective of level of control], human immunodeficiency virus infection or acquired immunodeficiency syndrome, use of medications associated with gingival hyperplasia).
  • 6.Unrestored dentinal caries.
  • 7.Treatment with antibiotics or anti-inflammatory medication in the month prior to starting the study.
  • 8.Concomitant pharmacotherapy with drugs that may interact with test drug.
  • 9.History of conditions requiring antibiotic coverage prior to invasive dental procedures.
  • 10.Pregnancy/lactation.

研究者

相似试验